(Q40476949)

20 September 2017

title

Bioactive friedolanostanes and 11(10-->8)-abeolanostanes from the bark of Garcinia speciosa. (English)

1 reference

(E,6R)-6-[(1'aR,3R,3'R,3aS,3'aR,6S,7aR,7'aS)-6-hydroxy-3',3a,3'a,7,7-pentamethyl-6'-oxospiro[1,2,4,5,6,7a-hexahydroindene-3,7'-1a,2,4,5-tetrahydroindeno[3,3a-b]oxirene]-3'-yl]-2-methylhept-2-enoic acid

20 September 2017

1 reference

1 reference

(6R)-6-[(1'aR,3R,3'R,3aS,3'aR,6S,7aR,7'aS)-6-hydroxy-3',3a,3'a,7,7-pentamethyl-6'-oxospiro[1,2,4,5,6,7a-hexahydroindene-3,7'-1a,2,4,5-tetrahydroindeno[3,3a-b]oxirene]-3'-yl]-2-methylhept-2-enoic acid

1 reference

(2S,6R)-6-[(3S,5R,8S,10S,13S,14S)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,7,8,12,15-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoic acid

1 reference

(2E,4Z,6R)-6-[(1'aR,3R,3'R,3aS,3'aR,6S,7aR,7'aS)-6-hydroxy-3',3a,3'a,7,7-pentamethyl-6'-oxospiro[1,2,4,5,6,7a-hexahydroindene-3,7'-1a,2,4,5-tetrahydroindeno[3,3a-b]oxirene]-3'-yl]-2-methylhepta-2,4-dienoic acid

1 reference

1 reference

methyl (E)-3-[(4R,6R,8R,9S,10R,14S,17R,19R)-17-acetyloxy-8,9,10,14,18,18-hexamethyl-5-oxapentacyclo[11.8.0.02,10.04,9.014,19]henicosa-1(13),2-dien-6-yl]-2-methylprop-2-enoate

1 reference

(2S,6R)-6-[(3S,5R,8S,10S,13S,14S)-3-acetyloxy-4,4,10,13,14-pentamethyl-2,3,5,6,7,8,12,15-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoic acid

1 reference

methyl (E,4R,6R)-4-hydroxy-6-[(3R,5R,9R,10R,13S,17S)-3-hydroxy-4,4,10,13,17-pentamethyl-15-oxo-1,2,3,5,6,7,9,11,12,16-decahydrocyclopenta[a]phenanthren-17-yl]-2-methylhept-2-enoate

1 reference

(2S,6R)-6-[(3R,5R,8S,10S,13S,14S)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,7,8,12,15-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoic acid

1 reference

(6R)-6-[(1'aR,3R,3'R,3aS,3'aR,6S,7aR,7'aS)-6-hydroxy-3',3a,3'a,7,7-pentamethyl-6'-oxospiro[1,2,4,5,6,7a-hexahydroindene-3,7'-1a,2,4,5-tetrahydroindeno[3,3a-b]oxirene]-3'-yl]-2-methylhepta-2,4-dienoic acid

1 reference

methyl (2S,6R)-6-[(3S,5R,8S,10S,13S,14S)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,7,8,12,15-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoate

1 reference

(E,4S,6R)-6-[(1'aR,3R,3'R,3aS,3'aR,6R,7aR,7'aS)-6-hydroxy-3',3a,3'a,7,7-pentamethyl-6'-oxospiro[1,2,4,5,6,7a-hexahydroindene-3,7'-1a,2,4,5-tetrahydroindeno[3,3a-b]oxirene]-3'-yl]-4-hydroxy-2-methylhept-2-enoic acid

1 reference

methyl (E)-3-[(4R,6R,8R,9S,10R,14S,17R,19R)-17-hydroxy-8,9,10,14,18,18-hexamethyl-5-oxapentacyclo[11.8.0.02,10.04,9.014,19]henicosa-1(13),2-dien-6-yl]-2-methylprop-2-enoate

1 reference

1 reference

2

1 reference

20 September 2017

9

Werner Herz

1 reference

20 September 2017

Luis M M Vieira

1

1 reference

20 September 2017

Rujida Wilairat

3

1 reference

20 September 2017

Maria São José Nascimento

4

1 reference

20 September 2017

Luis Gales

5

1 reference

20 September 2017

Ana Margarida Damas

6

1 reference

20 September 2017

Artur M S Silva

7

1 reference

20 September 2017

Ing-On Mondranondra

8

1 reference

20 September 2017

publication date

1 December 2004

1 reference

Journal of Natural Products

20 September 2017

published in

1 reference

20 September 2017

volume

67

1 reference

20 September 2017

issue

12

1 reference

20 September 2017

page(s)

2043-2047

1 reference

Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines

20 September 2017

cites work

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1093/JNCI/83.11.757

Identifiers

DOI

10.1021/NP049773H

1 reference

20 September 2017

1 reference